Humacyte, Inc. (HUMA) stock
HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.50−0.04 (-7.27%)
Close on Nov 17, 2026Market cap $139.18MP/E –Yield –
Humacyte net income
Net income is the profit left for shareholders after every expense, interest and tax.
Humacyte's net income for the twelve months ending Jun 30, 2026 was -$96.74M. For fiscal 2025 it was -$40.83M. The highest annual figure on record is -$11.97M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$40.83M | – |
| FY2024 | Dec 31, 2024 | -$148.70M | – |
| FY2023 | Dec 31, 2023 | -$110.78M | – |
| FY2022 | Dec 31, 2022 | -$11.97M | – |
| FY2021 | Dec 31, 2021 | -$26.48M | – |
| FY2020 | Dec 31, 2020 | -$66.52M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$36.80M | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.62M | -145.0% |
| Q4 FY2025 | Dec 31, 2025 | -$24.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$37.66M | – |
| Q1 FY2025 | Mar 31, 2025 | $39.14M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$39.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$56.66M | – |
| Q1 FY2024 | Mar 31, 2024 | -$31.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$25.11M | – |
| Q3 FY2023 | Sep 30, 2023 | -$26.00M | – |
| Q2 FY2023 | Jun 30, 2023 | -$22.71M | -161.6% |
| Q1 FY2023 | Mar 31, 2023 | -$36.97M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.72M | -108.7% |
| Q3 FY2022 | Sep 30, 2022 | -$25.28M | – |
| Q2 FY2022 | Jun 30, 2022 | $36.87M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.83M | – |
| Q4 FY2021 | Dec 31, 2021 | $42.59M | – |
| Q3 FY2021 | Sep 30, 2021 | -$31.56M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.20M | – |
| Q1 FY2021 | Mar 31, 2021 | -$20.30M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.21M | – |
| Q3 FY2020 | Sep 30, 2020 | -$17.76M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.88M | – |
| Q1 FY2020 | Mar 31, 2020 | -$17.67M | – |
See a number that looks wrong?